Literature DB >> 14756216

Injection practices in Romania: progress and challenges.

Catherine Dentinger1, Lili Pasat, Mircea Popa, Yvan J E Hutin, Eric E Mast.   

Abstract

OBJECTIVE: To identify breaks in infection control practices that might put Romanians at risk for transmission of hepatitis B virus (HBV) from injections.
METHODS: A standardized questionnaire was administered to a systematic sample of the 1,906 nurses in Vâlcea District, Romania, to collect information on their knowledge, attitudes, and practices regarding injection administration and universal precautions.
RESULTS: Of the 180 nurses interviewed, 91% (95% confidence interval [CI95], 86% to 95%) reported having attended training for universal precautions; 58% (CI95, 49% to 67%) accurately reported that HBV remains infectious for at least 1 week in the environment; and 4% (CI95, 2% to 8%) knew that HBV is transmitted more efficiently than HIV through percutaneous exposures. No nurses reported reusing syringes or needles on different patients, but 4 (2%; CI, 1% to 6%) would reuse a syringe and 3 (2%; CI95, 0% to 5%) would reuse a needle on the same patient in an emergency. Fifty-three percent (CI95, 44% to 61%) of nurses reported having a dedicated area for the preparation of injectable medications separate from where blood-contaminated items were handled. Shortages of infection control supplies were common.
CONCLUSIONS: Although nurses in Vâlcea do not report reusing injection equipment without sterilization, other unsafe practices occur that may facilitate HBV transmission through injections, including preparing injectable medications in areas potentially contaminated with blood. Inadequate knowledge of blood-borne pathogen transmission and shortages of infection control supplies may contribute to these unsafe practices. Addressing these deficits could improve injection safety in Romania.

Entities:  

Mesh:

Year:  2004        PMID: 14756216     DOI: 10.1086/502288

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Influence of social changes on the evolution of HIV infection in Romania.

Authors:  Simona Rutã; Costin Cernescu
Journal:  Int J Environ Stud       Date:  2008

Review 2.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Chiara Sorrentino; Alessandra Lo Presti; Elisabetta Tanzi; Massimo Ciccozzi; Massimo Galli
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

3.  Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin.

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Renata Shkjezi; Alessia Lai; Chiara Sorrentino; Alessandra Lo Presti; Mimoza Basho; Raffaele Bruno; Elisabetta Tanzi; Silvia Bino; Massimo Ciccozzi; Massimo Galli
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

4.  Occupational exposure to blood and body fluids among health-care workers in Serbia.

Authors:  Ljiljana Markovic-Denic; Natasa Maksimovic; Vuk Marusic; Jelena Vucicevic; Irena Ostric; Dusan Djuric
Journal:  Med Princ Pract       Date:  2014-11-01       Impact factor: 1.927

5.  The level of safety standards in implementing therapeutic and caring procedures by emergency department personnel.

Authors:  Motahareh Musavi Ghahfarokhi; Leila Masoudiyekta; Nasrin Khajeali
Journal:  Nurs Open       Date:  2018-09-14

Review 6.  Injection practices in 2011-2015: a review using data from the demographic and health surveys (DHS).

Authors:  Tomoyuki Hayashi; Yvan J-F Hutin; Marc Bulterys; Arshad Altaf; Benedetta Allegranzi
Journal:  BMC Health Serv Res       Date:  2019-08-27       Impact factor: 2.655

7.  Prevalence and risk factors of needle stick and sharp injury among tertiary hospital workers, Vientiane, Lao PDR.

Authors:  Chieko Matsubara; Kayako Sakisaka; Vanphanom Sychareun; Alongkone Phensavanh; Moazzam Ali
Journal:  J Occup Health       Date:  2017-09-13       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.